Byetta Lawsuits

Byetta was approved by the FDA in April 28, 2005 for treatment of Type II Diabetes. The drug is manufactured by Amylin Pharmaceuticals Inc. and previously was marketed by Eli Lilly & Co.

Byetta is an injectable drug intended to allow diabetics to better regulate their blood sugar levels. The injection is administered twice daily and encourages insulin production.
Studies Link Byetta to Pancreatic Cancer and Thyroid Cancer

The FDA has issued two safety alerts concerning Byetta. The agency reported in August 2008 that it had reviewed 30 reports of acute pancreatitis in patients taking Byetta. The FDA also asked Amylin Pharmaceuticals to add stronger and more prominent warnings to the label advising patients about the risk of pancreatitis.

Two studies have demonstrated a link between Byetta and pancreatitis, which often leads to the development of pancreatic cancer.

The FDA has advised medical providers to counsel Byetta patients to seek emergency medical attention if they develop symptoms of unexplained, persistent and severe abdominal pain. These symptoms can be a result of acute pancreatitis.

If you have taken Byetta and developed pancreatic cancer or thyroid cancer, you may be entitled to compensation. You should act immediately to contact a lawyer experienced in matters involving dangerous pharmaceuticals.

Our Awards